Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q88777099 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010737.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q88777099 | ||
| 024 | ‡a 0000-0002-0246-4111 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q88777099 | ||
| 100 | 0 | ‡a Maria Garayar Cantero ‡c researcher ‡9 en | |
| 375 | ‡a 2 ‡2 iso5218 | ||
| 400 | 0 | ‡a M Garayar Cantero ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Muir-Torre syndrome | ||
| 670 | ‡a Author's Use of botulinum toxin in the treatment of aquagenic keratoderma: One case report | ||
| 670 | ‡a Author's Use of low-dose naltrexone in the treatment of severe Hailey-Hailey disease: One case report | ||
| 670 | ‡a Author's Use of Permethrin in the Treatment of Rosacea Fulminans During Pregnancy: One Case Report | ||
| 670 | ‡a Author's Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients | ||
| 909 | ‡a (orcid) 0000000202464111 ‡9 1 | ||
| 919 | ‡a muirtorresyndrome ‡A Muir-Torre syndrome ‡9 1 | ||
| 919 | ‡a vascularobliterationbecauseofendothelialandmyointimalgrowthincovid19patients ‡A Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients ‡9 1 | ||
| 919 | ‡a useofpermethrininthetreatmentofrosaceafulminansduringpregnancy1casereport ‡A Use of Permethrin in the Treatment of Rosacea Fulminans During Pregnancy: One Case Report ‡9 1 | ||
| 919 | ‡a useoflowdosenaltrexoneinthetreatmentofseverehaileyhaileydisease1casereport ‡A Use of low-dose naltrexone in the treatment of severe Hailey-Hailey disease: One case report ‡9 1 | ||
| 919 | ‡a useofbotulinumtoxininthetreatmentofaquagenickeratoderma1casereport ‡A Use of botulinum toxin in the treatment of aquagenic keratoderma: One case report ‡9 1 | ||
| 946 | ‡a a ‡9 1 | ||
| 996 | ‡2 DBC|87097990358537 | ||
| 996 | ‡2 BNE|XX939212 | ||
| 996 | ‡2 ISNI|0000000059516221 | ||
| 996 | ‡2 ISNI|0000000080636957 | ||
| 996 | ‡2 LC|nb2012027247 | ||
| 996 | ‡2 ISNI|000000004058817X | ||
| 996 | ‡2 SUDOC|112466117 | ||
| 996 | ‡2 BNE|XX1749949 | ||
| 996 | ‡2 ISNI|0000000118407026 | ||
| 996 | ‡2 LC|no2010021290 | ||
| 996 | ‡2 BNE|XX5733207 | ||
| 996 | ‡2 SUDOC|083450971 | ||
| 996 | ‡2 BNE|XX5451341 | ||
| 996 | ‡2 SUDOC|264299698 | ||
| 996 | ‡2 ISNI|0000000376296103 | ||
| 996 | ‡2 DNB|1060685221 | ||
| 996 | ‡2 BNC|981058610541206706 | ||
| 996 | ‡2 BNE|XX4866434 | ||
| 996 | ‡2 BNF|15113122 | ||
| 996 | ‡2 ISNI|0000000420536072 | ||
| 996 | ‡2 LC|n 2005002330 | ||
| 996 | ‡2 BIBSYS|6041533 | ||
| 996 | ‡2 PLWABN|9813660054805606 | ||
| 996 | ‡2 LC|n 2004154113 | ||
| 996 | ‡2 BNC|981058611406106706 | ||
| 996 | ‡2 RERO|A012651588 | ||
| 996 | ‡2 NII|DA15362446 | ||
| 996 | ‡2 DNB|105761016X | ||
| 996 | ‡2 BIBSYS|1512647517975 | ||
| 996 | ‡2 ISNI|0000000387374859 | ||
| 996 | ‡2 ISNI|0000000059927514 | ||
| 996 | ‡2 BNC|981058515526306706 | ||
| 996 | ‡2 LC|no2024120848 | ||
| 996 | ‡2 BNE|XX4580121 | ||
| 996 | ‡2 DNB|1293177865 | ||
| 996 | ‡2 BNE|XX4809294 | ||
| 996 | ‡2 BNF|16741639 | ||
| 996 | ‡2 W2Z|1512647517975 | ||
| 996 | ‡2 LC|n 2013187598 | ||
| 996 | ‡2 ISNI|0000000120540360 | ||
| 996 | ‡2 BNF|15047384 | ||
| 996 | ‡2 SUDOC|137609167 | ||
| 996 | ‡2 LC|n 96061397 | ||
| 996 | ‡2 RERO|A012679318 | ||
| 996 | ‡2 ISNI|0000000036129878 | ||
| 996 | ‡2 ISNI|0000000121432927 | ||
| 996 | ‡2 LC|no2005121556 | ||
| 996 | ‡2 SUDOC|113510128 | ||
| 996 | ‡2 BNC|981058508026306706 | ||
| 996 | ‡2 ISNI|0000000115905839 | ||
| 996 | ‡2 NUKAT|n 2006124842 | ||
| 996 | ‡2 BNF|17120530 | ||
| 996 | ‡2 DNB|1333368607 | ||
| 996 | ‡2 BNE|XX4447731 | ||
| 996 | ‡2 BNE|XX4420696 | ||
| 996 | ‡2 BNE|XX1107659 | ||
| 996 | ‡2 LC|n 2008045252 | ||
| 996 | ‡2 ISNI|0000000110678083 | ||
| 996 | ‡2 PTBNP|1611583 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
